No definition available.
Allergic contact dermatitis due to drugs in contact with skin
ALLERGIC_CONTACT_DERMA_DRUGS_CONTACT_W_SKIN
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
808 |
4. Check minimum number of eventsNone |
808 |
5. Include endpointsNone |
808 |
6. Filter based on genotype QC (FinnGen only) |
808 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF5
Similar endpoints
↥List of similar endpoints to
Allergic contact dermatitis due to drugs in contact with skin
based on the number of shared cases.
Similar with more cases:
- Allergic contact dermatitis
- Dermatitis and eczema
- Diseases of the skin and subcutaneous tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 5347 | 3692 | 1635 |
| Only index persons | 5018 | 3503 | 1515 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.09 | 0.11 | 0.05 |
| Only index persons | 0.11 | 0.13 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 53.77 | 53.75 | 53.80 |
| Only index persons | 53.05 | 52.95 | 53.27 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 808 | 572 | 236 |
| Unadjusted period prevalence (%) | 0.17 | 0.19 | 0.10 |
| Median age at first event (years) | 55.26 | 52.96 | 60.83 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 724
- Matched controls
- 7240
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L23.3
ICD-10 Finland
Allergic contact dermatitis due to drugs in contact with skin
4503599627370496.0
323.0
722
*
XQ802
NOMESCO Finland
Epicutan test
44.3
272.8
343
144
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
18.6
213.6
368
381
XQ800
NOMESCO Finland
Prick test
13.9
139.9
263
286
L23.2
ICD-10 Finland
Allergic contact dermatitis due to cosmetics
71.8
119.2
135
23
L23.0
ICD-10 Finland
Allergic contact dermatitis due to metals
68.2
117.4
134
24
L30.9
ICD-10 Finland
Dermatitis, unspecified
6.8
101.1
314
736
E0000UV
ATC
NA
4.4
75.6
463
2093
L23.5
ICD-10 Finland
Allergic contact dermatitis due to other chemical products
53.7
64.9
77
16
D07AC13
ATC
mometasone; topical
4.0
64.6
367
1473
D07AC01
ATC
betamethasone; topical
3.8
60.9
391
1716
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
12.3
59.1
111
105
L20.0
ICD-10 Finland
Besnier prurigo
7.7
58.7
147
232
R06AE07
ATC
cetirizine; oral
3.4
54.3
447
2308
D07AB08
ATC
desonide; topical
5.5
52.1
173
392
E000001
ATC
NA
3.8
49.6
269
981
L23.9
ICD-10 Finland
Allergic contact dermatitis, unspecified cause
40.0
47.1
59
16
L23.1
ICD-10 Finland
Allergic contact dermatitis due to adhesives
71.3
46.8
53
8
L23.8
ICD-10 Finland
Allergic contact dermatitis due to other agents
46.6
46.1
56
13
L30.3
ICD-10 Finland
Infective dermatitis
10.2
41.7
85
93
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
4.0
38.8
179
551
D07AD01
ATC
clobetasol; topical
3.6
36.8
195
671
H02AB06
ATC
prednisolone; systemic
2.7
36.4
430
2526
D07AB02
ATC
hydrocortisone butyrate; topical
2.9
36.3
302
1432
D07CC01
ATC
betamethasone and antibiotics; topical
3.6
31.8
162
533
D07BC01
ATC
betamethasone and antiseptics; topical
3.5
29.0
150
497
D02AE01
ATC
carbamide; topical
4.7
27.4
99
236
E000006
ATC
NA
4.0
25.8
110
307
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.8
25.8
119
356
R06AX27
ATC
desloratadine; oral
2.4
24.0
259
1347
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
11.1
23.6
45
43
D09AB01
ATC
zinc bandage without supplements; topical
9.8
23.1
47
51
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.5
22.6
218
1063
R06AE09
ATC
levocetirizine; oral
2.9
22.4
156
629
D02AX
ATC
Other emollients and protectives
6.0
22.1
63
114
XQ899
NOMESCO Finland
Other assessment of skin
32.3
21.6
28
9
L23
ICD-10 Finland
Allergic contact dermatitis
44.8
21.5
26
6
T78.4
ICD-10 Finland
Allergy, unspecified
5.1
21.3
69
146
TQW80
NOMESCO Finland
Local dermatologic skincare
7.5
20.7
49
69
D07XC01
ATC
betamethasone, combinations; topical
3.1
19.9
121
444
L30.8
ICD-10 Finland
Other specified dermatitis
8.9
19.7
42
50
E000002
ATC
NA
2.9
19.6
130
503
N05BB01
ATC
hydroxyzine; systemic
4.0
19.2
81
223
L27.0
ICD-10 Finland
Generalized skin eruption due to drugs and medicaments
11.8
19.2
35
31
D07AA02
ATC
hydrocortisone; topical
2.8
19.1
138
564
D07BA04
ATC
hydrocortisone and antiseptics; topical
3.1
18.6
109
389
C01CA24
ATC
epinephrine; parenteral
3.8
17.8
80
232
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.5
17.5
85
263
L30.0
ICD-10 Finland
Nummular dermatitis
5.7
16.9
49
91
D11AH01
ATC
tacrolimus; topical
13.1
16.8
29
23
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
4.5
16.0
57
134
WXQ27
NOMESCO Finland
UVB narrow spectrum light therapy
10.1
15.8
31
32
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.5
15.5
129
569
R06AX22
ATC
ebastine; oral
2.3
15.3
158
778
E000003
ATC
NA
4.0
15.0
61
163
H02AB07
ATC
prednisone; oral
2.4
14.7
134
620
J01FF01
ATC
clindamycin; systemic
2.0
14.5
216
1248
L50.0
ICD-10 Finland
Allergic urticaria
5.4
12.4
37
72
R03AC02
ATC
salbutamol; inhalant
1.8
12.4
391
2893
J01DB01
ATC
cefalexin; oral
2.0
12.2
593
5038
XQ801
NOMESCO Finland
Intracutantest
23.3
11.6
16
7
S01GX01
ATC
cromoglicic acid; ophthalmic
2.0
11.6
172
979
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.7
11.0
303
2124
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
5.0
10.9
34
70
S29
ICPC
Skin symptom/complaint other
2.1
10.9
140
751
R06AX13
ATC
loratadine; oral
2.1
10.7
128
666
H02AB04
ATC
methylprednisolone; systemic
2.1
10.5
128
668
L23.7
ICD-10 Finland
Allergic contact dermatitis due to plants, except food
+∞
10.4
10
*
XQ820
NOMESCO Finland
Exposure to medicinal substance
19.1
10.3
15
8
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
3.8
10.3
42
114
C05AA08
ATC
fluocortolone; rectal, topical
2.2
9.9
112
566
E000007
ATC
NA
2.9
9.9
61
223
J02AC02
ATC
itraconazole; systemic
2.0
9.7
143
807
E000004
ATC
NA
4.7
9.7
32
71
J01DA01
ATC
[U] cefalexin; systemic
1.7
9.6
453
3639
L29.9
ICD-10 Finland
Pruritus, unspecified
5.4
9.6
28
54
H01.0
ICD-10 Finland
Blepharitis
3.3
9.6
47
148
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
2.4
9.6
83
372
L50.9
ICD-10 Finland
Urticaria, unspecified
3.6
9.4
41
118
L20
ICD-10 Finland
Atopic dermatitis
4.2
9.4
34
83
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
5.6
9.0
25
46
L26
ICD-10 Finland
Exfoliative dermatitis
50.6
8.7
10
*
J02AC01
ATC
fluconazole; systemic
1.6
8.6
309
2284
SPAT1263
SPAT
Sampling
1.6
8.6
310
2294
S88
ICPC
Dermatitis contact/allergic
4.8
8.5
27
58
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
8.5
280
2022
D11AX14
ATC
[U] tacrolimus; topical
10.9
8.3
15
14
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.9
8.3
128
732
R01AD08
ATC
fluticasone; nasal
1.7
8.2
205
1368
L40.0
ICD-10 Finland
Psoriasis vulgaris
3.2
8.2
42
138
A46
ICD-10 Finland
Erysipelas
2.0
8.2
102
538
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
2.3
8.1
77
360
R03DC03
ATC
montelukast; oral
1.9
7.9
122
695
S87
ICPC
Dermatitis/atopic eczema
4.2
7.8
28
69
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
7.7
153
952
R03BA05
ATC
fluticasone; inhalant
1.8
7.6
135
808
J01AA04
ATC
lymecycline; systemic
2.0
7.6
96
509
L17
ICPC
Foot/toe symptom/complaint
1.7
7.6
180
1183
L50.8
ICD-10 Finland
Other urticaria
4.7
7.6
24
52
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
3.8
7.4
30
82
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
5.4
7.4
21
40
A02BC05
ATC
esomeprazole; systemic
1.6
7.4
284
2112
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
7.4
247
1773
L01
ICPC
Neck symptom/complaint
2.0
7.4
100
545
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
4.2
7.4
26
63
D07AB01
ATC
clobetasone; topical
3.2
7.4
36
115
D11AH04
ATC
alitretinoin; oral
+∞
7.3
7
*
D07XB05
ATC
dexamethasone, combinations; topical
3.7
7.2
30
84
J01CF05
ATC
flucloxacillin; systemic
3.3
7.2
34
106
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
7.2
116
674
L24.0
ICD-10 Finland
Irritant contact dermatitis due to detergents
20.2
7.1
10
5
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
7.0
199
1367
L30.1
ICD-10 Finland
Dyshidrosis [pompholyx]
13.9
6.9
11
8
D07AC14
ATC
methylprednisolone aceponate; topical
2.6
6.7
47
188
L23.4
ICD-10 Finland
Allergic contact dermatitis due to dyes
22.7
6.7
9
*
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
6.5
6.7
16
25
A92
ICPC
Allergy/allergic reaction NOS
3.8
6.5
26
71
M54.5
ICD-10 Finland
Low back pain
1.6
6.4
226
1636
N02BE01
ATC
paracetamol; systemic, rectal
1.6
6.4
598
5377
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.5
6.4
48
201
D05BB02
ATC
acitretin; oral
3.9
6.3
24
63
L56.4
ICD-10 Finland
Polymorphous light eruption
11.1
6.3
11
10
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
2.9
6.3
36
127
XG410
NOMESCO Finland
Flow-volume spirometry
2.8
6.3
37
135
D07AC03
ATC
desoximetasone; topical
4.8
6.3
19
40
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.3
6.3
54
244
WQ007
NOMESCO Finland
NA
26.9
6.2
8
*
J30.3
ICD-10 Finland
Other allergic rhinitis
3.1
6.2
31
102
D07XB02
ATC
triamcinolone, combinations; topical
5.4
6.2
17
32
XQ848
NOMESCO Finland
Dermatological photography
3.8
6.1
24
65
A02BC02
ATC
pantoprazole; systemic
1.5
6.1
445
3756
J01DC02
ATC
cefuroxime; systemic
2.6
6.1
43
174
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
6.1
95
544
S01ED02
ATC
betaxolol; ophthalmic
6.8
6.1
14
21
L25.9
ICD-10 Finland
Unspecified contact dermatitis, unspecified cause
6.8
6.1
14
21
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
4.2
6.0
21
51
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
6.0
80
430
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.8
6.0
95
549
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005322) IgE [Units/volume] in Serum or Plasma
150
434
4.02
46.02
1.6
1.2
u/ml
578.8
209.1
1.71
143
398
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
180
840
2.47
23.01
4.5
4.4
%
32.0
32.2
0.07
125
556
(40768443) Skin Pathology biopsy report
87
289
3.25
21.06
1.4
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
441
3012
2.02
21.03
7.1
5.7
%
0.7
0.7
0.16
415
2813
(3000494) Fungus identified in Specimen by Culture
171
821
2.37
20.31
2.0
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
448
3102
2.00
20.26
7.2
5.7
%
3.3
2.8
3.59
423
2896
(3013707) Erythrocyte sedimentation rate by Westergren method
635
4998
2.26
20.16
4.9
4.1
mm/h
12.4
12.0
0.21
587
4606
(3018010) Neutrophils/100 leukocytes in Blood
453
3164
1.98
19.81
7.0
5.5
%
56.0
57.2
1.30
428
2975
(3019069) Monocytes/100 leukocytes in Blood
448
3118
1.98
19.78
7.7
6.0
%
8.6
8.5
0.43
425
2930
(3002030) Lymphocytes/100 leukocytes in Blood
456
3205
1.97
19.43
7.5
5.8
%
28.1
28.1
0.04
430
2999
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
48
114
4.41
18.80
1.1
1.1
u/ml
0.9
1.6
0.50
18
48
(3019225) pH of Specimen
141
643
2.45
18.67
4.4
4.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
17
12
14.45
18.53
1.0
1.1
—
—
—
0
0
(3013512) EKG study
306
1911
1.97
18.11
4.9
3.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
473
3448
1.90
17.19
6.9
5.9
e9/l
0.2
0.2
3.29
429
3059
(42870588) Differential panel, method unspecified - Blood
335
2187
1.91
17.14
6.7
5.7
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
43
102
4.40
16.87
1.1
1.0
u/ml
7.6
3.2
0.55
22
53
(3019198) Lymphocytes [#/volume] in Blood
466
3409
1.87
16.44
6.9
5.6
e9/l
2.0
1.9
0.49
424
3029
(3001604) Monocytes [#/volume] in Blood
454
3315
1.84
15.90
6.9
5.6
e9/l
0.6
0.6
2.95
414
2882
(3006315) Basophils [#/volume] in Blood
455
3328
1.84
15.81
6.9
5.6
e9/l
0.0
0.0
1.96
412
2900
(3004616) Nuclear Ab [Presence] in Serum
36
86
4.33
14.00
1.3
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
306
2089
1.75
12.54
3.0
2.4
u/l
53.5
55.4
0.57
277
1932
(3007853) Bacteria identified in Skin by Aerobe culture
140
744
2.07
12.51
2.4
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
554
4468
1.76
12.27
4.2
3.0
u/l
46.2
44.6
0.19
505
4174
(3037522) Nuclear Ab [Titer] in Serum
165
937
1.96
12.22
1.5
1.3
titre
664.0
504.7
0.36
35
204
(3013650) Neutrophils [#/volume] in Blood by Automated count
494
3880
1.70
11.83
9.3
8.8
e9/l
4.1
4.1
0.15
445
3411
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
617
5161
1.83
11.77
9.4
7.3
u/l
77.4
77.8
0.08
583
4835
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
366
2680
1.67
11.24
2.2
2.0
pmol/l
97.5
96.2
0.16
182
1361
(3008401) Mugwort IgE Ab [Units/volume] in Serum
34
96
3.65
10.57
1.0
1.1
u/ml
0.5
0.7
0.20
17
43
(3019309) Folate [Moles/volume] in Red Blood Cells
191
1188
1.80
10.50
1.7
1.7
nmol/l
1051.9
1193.5
1.25
137
887
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
61
250
2.56
10.01
4.9
4.1
mmol/l
25.3
25.0
0.46
54
238
(3037467) Urinalysis macro (dipstick) panel - Urine
558
4636
1.66
9.77
5.7
4.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
416
3227
1.60
9.60
7.8
6.5
mmol/l
1.2
1.2
0.39
354
2728
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
437
3444
1.59
9.32
6.8
6.0
umol/l
10.1
11.0
1.56
411
3267
(3032080) INR in Blood by Coagulation assay
346
2587
1.59
9.22
9.3
8.6
inr
1.2
1.2
0.05
88
764
(3013826) Glucose [Moles/volume] in Serum or Plasma
472
3809
1.58
8.92
5.1
4.5
mmol/l
6.6
6.6
0.18
441
3556
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
79
385
2.17
8.77
4.7
3.5
mmol/l
1.8
1.8
0.03
66
290
(3022313) Gas panel - Capillary blood
65
295
2.31
8.56
4.8
3.6
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
14
22
6.46
8.55
1.0
1.0
u/ml
0.6
0.9
—
5
11
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
332
2502
1.55
8.30
4.6
3.6
ng/l
200.7
51.0
0.40
231
1692
(1761482) Bacteria [#/volume] in Urine by Culture
46
181
2.63
8.22
5.3
4.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
112
635
1.89
8.17
2.3
2.0
nmol/l
384.7
375.7
0.15
101
588
(3019550) Sodium [Moles/volume] in Serum or Plasma
746
6858
2.14
7.90
20.6
15.3
mmol/l
139.6
139.7
0.59
722
6670
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
80
410
2.06
7.80
4.7
3.5
kpa
5.2
5.1
0.49
73
383
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
238
1685
1.58
7.71
2.3
2.1
mg/l
2.7
3.0
1.10
208
1434
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
374
2927
1.52
7.68
6.2
5.7
mmol/l
1.2
1.2
0.49
321
2646
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
28
87
3.30
7.58
2.3
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
613
5348
1.61
7.52
5.1
4.0
pmol/l
14.9
14.7
1.09
548
4862
(3023103) Potassium [Moles/volume] in Serum or Plasma
746
6880
2.10
7.47
20.8
15.4
mmol/l
4.0
4.0
0.08
722
6679
(3025468) Yersinia sp identified in Specimen by Organism specific culture
27
84
3.29
7.30
2.3
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
27
84
3.29
7.30
2.3
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
27
85
3.25
7.17
2.3
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
27
86
3.21
7.04
2.3
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
67
334
2.10
7.03
5.1
3.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
27
87
3.18
6.92
2.3
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
52
237
2.28
6.81
1.6
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
248
1818
1.53
6.73
3.2
3.0
ng/l
1491.3
1186.8
0.51
197
1542
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
692
6282
1.71
6.61
6.1
4.8
mu/l
1.9
2.1
0.38
625
5761
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
762
7130
2.21
6.59
13.7
10.1
u/l
25.4
24.9
0.42
743
6880
(3022948) Iron [Moles/volume] in Serum or Plasma
152
1002
1.64
6.50
2.6
2.3
umol/l
12.8
13.1
0.29
142
919
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
266
1992
1.50
6.48
2.3
2.1
u/l
167.1
205.9
0.49
251
1877
(3042936) Bacteria identified in Isolate by Culture
145
947
1.65
6.43
2.6
1.9
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
28
97
2.95
6.37
1.0
1.1
u/ml
5.7
3.1
—
6
20
(3023368) Bacteria identified in Blood by Culture
233
1704
1.52
6.34
5.2
4.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
212
1520
1.54
6.32
1.9
1.6
mg/l
0.9
1.1
0.90
155
1172
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
43
190
2.33
6.07
1.5
1.2
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
140
920
1.63
6.04
2.5
2.3
g/l
2.4
2.3
0.27
130
850
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
36
147
2.52
6.02
2.2
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
354
2837
1.44
5.97
2.7
2.3
nmol/l
79.4
77.2
0.79
309
2535
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
80
452
1.85
5.89
2.4
1.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
93
551
1.78
5.87
1.3
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
18
50
3.66
5.78
1.9
1.1
u/ml
0.8
1.1
—
9
23
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
32
4.43
5.78
1.7
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
32
4.43
5.78
1.7
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
706
6501
1.68
5.67
5.1
4.4
mmol/l
5.8
5.9
0.81
634
5936
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
689
6307
1.63
5.65
15.5
12.4
ml/min/173m2
80.9
81.9
0.54
606
5161
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
15
37
4.11
5.64
1.7
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
15
37
4.11
5.64
1.7
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
722
6704
1.72
5.41
20.0
13.5
mg/l
18.9
22.6
2.61
609
5264
(3002179) Metamyelocytes/100 leukocytes in Blood
83
489
1.78
5.35
4.4
4.1
%
0.6
0.5
0.12
21
115
(3014133) Dog dander IgE Ab [Units/volume] in Serum
23
79
2.97
5.34
1.0
1.0
u/ml
14.8
2.2
—
10
27
(3026389) Candida sp identified in Specimen by Organism specific culture
23
79
2.97
5.34
1.4
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
211
1559
1.48
5.34
1.4
1.3
u/ml
3.9
2.0
0.50
38
420
(3021960) Folate [Moles/volume] in Serum or Plasma
212
1569
1.48
5.31
1.6
1.5
nmol/l
19.8
21.5
0.73
174
1330
(3045424) Erythrocytes [Presence] in Urine
28
110
2.60
5.09
1.1
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
512
4456
1.41
5.06
5.6
4.5
e6/l
403.3
3048.5
—
7
70
(3047007) Chlamydophila sp Ab [Presence] in Serum
26
100
2.65
4.93
1.3
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
45
222
2.09
4.91
1.8
2.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
188
1380
1.47
4.87
1.3
1.5
g/l
2.5
2.3
0.88
115
842
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
44
219
2.07
4.70
1.5
1.6
—
182.0
—
0
10
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
148
1042
1.51
4.69
2.2
1.9
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
21
74
2.89
4.68
1.0
1.1
u/ml
11.2
5.6
—
7
26
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
126
858
1.56
4.65
2.8
2.3
%
21.2
22.7
0.81
105
741
(3037121) Protein [Mass/volume] in Urine
45
231
2.00
4.44
3.0
3.3
g/l
0.3
0.3
0.49
18
87
(3025159) Blasts/100 leukocytes in Blood
78
478
1.70
4.40
4.7
4.3
%
0.0
0.9
0.63
25
121
(3021440) Promyelocytes/100 leukocytes in Blood
82
510
1.68
4.38
4.7
4.2
%
0.1
0.1
0.59
27
143
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
22
83
2.70
4.35
5.6
2.4
mg/l
18.3
24.4
0.48
11
25
(3012544) pH of Venous blood
92
593
1.62
4.28
6.7
3.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
83
522
1.66
4.25
1.9
2.9
g/l
65.6
66.9
0.74
74
478
(3017181) Myelocytes/100 leukocytes in Blood
86
547
1.64
4.22
4.6
4.0
%
0.8
1.0
0.40
28
162
(3012095) Magnesium [Moles/volume] in Serum or Plasma
144
1030
1.48
4.21
3.5
3.2
mmol/l
0.8
0.8
0.78
125
956
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
21
79
2.70
4.18
10.8
5.3
mg/l
10.2
11.5
0.91
21
70
(3044640) Blood type and Crossmatch panel - Blood
263
2099
1.38
4.18
3.0
2.3
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
11
27
4.12
4.17
1.6
1.2
ug/l
9.7
8.6
0.64
11
27
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
37
181
2.09
4.16
1.5
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
362
3041
1.34
4.12
3.0
2.7
ug/l
112.2
112.3
0.00
338
2804
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
62
363
1.77
4.11
1.7
1.8
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
25
104
2.45
4.09
1.1
1.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
272
2193
1.36
4.03
3.7
3.1
u/l
29.6
30.5
0.22
257
2088
(3007461) Platelets [#/volume] in Blood
776
7449
2.05
4.02
27.7
20.0
e9/l
255.5
253.9
0.28
762
7262
(3033705) Calcium.ionized [Moles/volume] in Venous blood
22
87
2.57
3.99
4.4
2.6
—
—
—
0
0
(3024731) MCV [Entitic volume]
776
7452
2.04
3.96
27.6
19.9
fl
91.1
91.0
0.24
767
7343
(3035941) MCH [Entitic mass]
776
7452
2.04
3.96
27.6
19.9
pg
30.3
30.3
0.09
767
7342
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
706
6615
1.53
3.96
5.0
4.3
mmol/l
4.7
4.7
0.17
644
6124
(3026361) Erythrocytes [#/volume] in Blood
776
7453
2.04
3.95
27.7
20.0
e12/l
4.4
4.5
1.43
758
7244
(3010813) Leukocytes [#/volume] in Blood
776
7454
2.04
3.93
27.8
20.1
e9/l
6.9
6.7
1.13
760
7244
(3017732) Neutrophils [#/volume] in Blood
73
454
1.67
3.91
2.5
3.0
e9/l
4.2
4.1
0.05
50
360
(3000963) Hemoglobin [Mass/volume] in Blood
776
7456
2.03
3.89
27.9
20.1
g/l
133.1
134.1
1.38
767
7344
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
50
281
1.83
3.81
1.7
2.3
u/l
40.9
39.7
0.13
44
250
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
107
741
1.51
3.66
2.3
2.4
umol/l
11.2
7.2
0.43
87
640
(3024561) Albumin [Mass/volume] in Serum or Plasma
329
2767
1.32
3.57
6.9
4.5
g/l
35.2
35.7
0.87
309
2584
(3002032) Base excess in Venous blood by calculation
86
571
1.57
3.56
6.9
3.2
mmol/l
1.9
2.0
0.08
77
449
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
44
243
1.86
3.55
2.0
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
680
6355
1.44
3.55
4.5
3.9
mmol/l
1.3
1.3
0.41
612
5819
(4024509)
16
57
2.84
3.54
1.9
1.4
—
—
—
0
0
(4010399)
75
483
1.61
3.52
1.4
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
700
6580
1.48
3.52
4.9
4.3
mmol/l
1.5
1.5
1.12
632
6061
(3026008) Bacteria identified in Urine by Culture
260
2124
1.33
3.43
3.9
3.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
46
261
1.81
3.42
2.5
1.9
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
35
182
1.96
3.38
1.7
2.4
mg/l
11.3
12.2
0.26
30
168
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
41
227
1.85
3.30
1.5
2.0
g/l
9.9
10.6
0.45
32
197
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
102
717
1.48
3.25
1.9
1.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
161
1231
1.38
3.25
1.3
1.3
iu/ml
45.4
31.7
0.30
45
409
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
12
38
3.19
3.22
1.2
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
245
1.80
3.17
1.5
2.0
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
245
1.80
3.17
1.5
2.0
g/l
8.1
7.5
0.85
26
189
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
43
245
1.80
3.17
1.5
2.0
g/l
4.3
3.7
1.65
25
181
(3048689) Calprotectin [Mass/mass] in Stool
115
832
1.45
3.17
2.9
2.2
ug/g
182.7
124.9
0.76
83
659
(40761511) CBC panel - Blood by Automated count
734
7001
1.53
3.06
19.0
12.9
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
199
1590
1.33
3.02
3.0
2.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
21
94
2.27
2.98
1.1
1.2
—
54.0
—
0
7
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
5
10.05
2.98
1.2
1.4
ng/l
107.2
67.2
—
5
5
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
710
6739
1.44
2.92
5.3
4.8
mmol/l
2.8
2.8
0.03
641
6207
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
10
30
3.36
2.91
1.0
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
324
2783
1.27
2.83
2.2
2.1
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
127
955
1.39
2.82
1.3
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
16
65
2.49
2.80
3.4
2.9
%
60.9
55.0
0.61
11
48
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
52
325
1.64
2.79
2.5
2.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
130
984
1.38
2.78
1.9
1.9
s
29.3
29.6
0.22
125
954
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
6
8.37
2.75
1.2
1.2
—
—
—
0
0
(3026782) Osmolality of Urine
164
1291
1.34
2.73
3.6
2.7
mosm/kgh2o
586.2
543.2
1.62
147
1102
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
361
3151
1.26
2.73
4.7
4.0
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
53
336
1.62
2.70
2.9
2.7
e6/l
0.2
0.2
0.00
53
325
(3051101) Glucose [Moles/volume] in Cord blood
6
10
6.04
2.70
2.8
4.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
21
99
2.15
2.66
1.2
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
103
756
1.42
2.64
1.3
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
47
291
1.65
2.63
2.1
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
67
453
1.52
2.60
1.5
2.4
—
—
—
0
0
(4015189)
7
15
4.70
2.60
1.7
4.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
5
7
7.18
2.55
1.0
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
69
2.35
2.49
1.1
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
652
6142
1.32
2.49
6.6
5.5
mmol/mol
40.0
39.4
0.73
584
5692
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
173
1392
1.31
2.47
1.6
1.7
pmol/l
470.7
22087394.6
1.32
146
1150
(3027945) Reticulocytes/100 erythrocytes in Blood
94
688
1.41
2.45
1.9
2.6
%
1.9
1.8
0.12
78
618
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
76
2.26
2.45
1.5
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
160
1276
1.32
2.43
1.7
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
267
2275
1.26
2.42
3.0
3.3
mmol/l
2.3
2.4
1.31
211
1984
(3008757) Leukocyte morphology finding [Identifier] in Blood
17
77
2.23
2.39
3.6
3.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
17
77
2.23
2.39
1.2
1.3
nmol/l
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
58
2.44
2.38
1.1
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
33
191
1.76
2.37
1.4
3.7
mg/l
59.0
83.5
0.29
28
151
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
31
178
1.77
2.29
1.3
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
8
23
3.50
2.27
4.0
1.3
umol/l
26.8
32.7
—
8
23
(3051387) C reactive protein [Mass/volume] in Capillary blood
27
149
1.84
2.27
3.3
3.9
mg/l
11.8
27.2
2.63
14
92
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
7
18
3.91
2.25
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
7
18
3.91
2.25
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
7
18
3.91
2.25
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
7
18
3.91
2.25
1.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
18
86
2.12
2.24
1.6
2.1
umol/l
6.6
5.1
0.35
12
57
(3013139) Helicobacter pylori Ag [Presence] in Stool
64
446
1.47
2.18
1.3
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
106
809
1.36
2.17
7.9
5.0
mmol/l
1.1
1.0
2.71
98
742
(3018095) Leukocytes [#/volume] in Urine
271
2338
1.24
2.16
4.1
3.6
e6/l
117.0
74.9
0.55
197
1633
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
147
1178
1.30
2.16
1.3
1.3
u/ml
7.7
12.9
0.39
52
455
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
30
3.02
2.15
2.6
3.6
u/ml
1053.8
816.0
—
9
30
(3026493) Urate [Moles/volume] in Serum or Plasma
197
1640
1.27
2.14
3.0
2.6
umol/l
5985.6
7048.7
0.12
174
1429
(3000570) Elastase.pancreatic [Mass/mass] in Stool
32
190
1.71
2.13
1.3
1.4
ug/g
269.3
296.1
0.27
20
115
(3052851) Hemolysis interference index of Serum or Plasma
32
190
1.71
2.13
2.7
3.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
32
191
1.70
2.09
1.4
3.7
mg/l
35.9
46.0
0.25
27
151
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
10
38
2.65
2.01
1.7
1.5
u/l
2.4
9.3
—
5
19
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
30
178
1.71
2.01
2.7
2.5
u/ml
0.4
0.4
0.02
18
98
(3041096) Erythrocytes [Presence] in Urine by Automated
217
1840
1.25
2.01
4.7
3.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
20
105
1.93
1.97
1.2
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
7
21
3.35
1.97
1.0
1.0
u/ml
79.8
28.7
—
7
21
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
7
21
3.35
1.97
10.3
5.2
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
14
64
2.21
1.95
1.3
1.3
g/l
3.2
2.5
—
7
44
(3027135) IgG subclass 1 [Mass/volume] in Serum
14
64
2.21
1.95
1.3
1.3
g/l
5.6
7.2
—
7
46
(3024139) IgG subclass 3 [Mass/volume] in Serum
14
64
2.21
1.95
1.3
1.3
g/l
0.4
0.3
—
7
44
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
11
4.57
1.94
1.2
1.1
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
370
3330
1.20
1.88
6.1
5.0
estimate
0.0
0.0
0.50
66
633
(3020682) Albumin/Creatinine [Ratio] in Urine
225
1929
1.23
1.87
4.1
4.0
mg/mmol
11.1
8.5
0.34
145
1195
(3035350) Ketones [Presence] in Urine by Test strip
368
3312
1.20
1.87
4.1
3.7
estimate
0.0
0.0
0.00
62
628
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
89
678
1.35
1.87
4.0
4.1
u/l
221.2
253.6
1.67
83
642
(4062490)
14
66
2.14
1.82
1.3
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
32
201
1.62
1.76
2.7
2.8
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
71
527
1.38
1.76
4.1
3.5
ng/l
131.7
77.8
1.16
59
475
(3036603) Volume of Urine
10
41
2.46
1.76
1.8
1.6
ml
2555.2
2094.9
—
5
7
(3022217) INR in Platelet poor plasma by Coagulation assay
99
774
1.32
1.75
24.2
23.6
inr
1.2
1.2
0.02
13
99
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
93
721
1.33
1.75
2.1
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
51
357
1.46
1.74
1.1
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
429
4642
0.84
1.72
3.7
3.7
—
—
—
0
0
(3020891) Body temperature
12
241
0.49
1.70
5.9
4.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
16
82
1.97
1.70
1.2
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
644
6140
1.24
1.70
18.4
14.4
%
37.5
39.5
3.63
450
4476
(3023520) Reticulocytes [#/volume] in Blood
68
506
1.38
1.67
2.0
2.7
e9/l
75.2
71.7
0.35
52
385
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
7
25
2.82
1.65
1.0
2.0
%
155.6
127.2
—
7
25
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
7
25
2.82
1.65
3.0
1.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
371
3371
1.19
1.63
4.3
3.7
estimate
0.0
0.0
0.80
67
614
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
14
3.59
1.61
1.0
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
35
231
1.54
1.59
1.6
2.0
g/l
3.4
3.1
0.45
25
185
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
33
2.44
1.54
3.1
2.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
33
217
1.54
1.53
1.8
1.6
iu/ml
12.0
0.1
—
5
35
(44806420)
5
15
3.35
1.52
2.2
2.7
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
7
27
2.61
1.51
1.0
1.6
%
99.9
109.2
—
7
27
(3020491) Glucose [Moles/volume] in Blood
11
51
2.17
1.51
1.1
1.8
mmol/l
5.3
6.5
—
5
32
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
58
2.09
1.49
1.2
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
143
1197
1.24
1.48
1.7
1.8
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
16
87
1.86
1.46
5.5
2.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
59
440
1.37
1.45
3.4
3.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
5
16
3.14
1.44
4.2
1.3
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
24
374
0.63
1.43
12.5
9.2
%
95.0
94.3
0.69
24
369
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
39
2.32
1.43
1.8
2.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
30
197
1.54
1.42
1.5
2.0
g/l
35.6
38.0
0.96
25
174
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
15
81
1.87
1.41
1.1
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
9
41
2.21
1.37
1.3
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
23
2.62
1.37
1.8
1.7
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
23
143
1.63
1.36
1.2
4.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
17
2.95
1.36
1.0
1.1
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
17
97
1.77
1.35
1.4
1.8
g/l
0.6
0.8
—
9
72
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
68
1.93
1.34
2.7
2.4
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
7
148
0.47
1.33
1.4
3.5
u/ml
14.4
27.9
—
7
143
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
122
1017
1.24
1.32
3.5
2.8
e6/l
2.4
3.0
0.58
78
547
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
24
2.51
1.30
1.8
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
43
2.11
1.30
1.2
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
14
76
1.86
1.30
1.9
2.1
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
8
34
2.37
1.29
1.3
1.1
u/l
105.0
91.7
—
8
26
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
8
34
2.37
1.29
1.3
1.1
u/l
18.0
31.1
—
8
26
(4146454)
12
62
1.95
1.28
2.5
2.8
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
48
2.10
1.28
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
8
35
2.30
1.27
1.4
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
14
77
1.83
1.26
1.1
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
32
220
1.47
1.25
1.7
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
94
768
1.25
1.23
1.8
1.7
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
11
56
1.98
1.22
2.5
2.1
e9/l
0.7
1.2
—
6
30
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
94
771
1.25
1.19
2.1
2.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
89
726
1.25
1.18
1.6
1.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
221
1969
1.17
1.18
3.9
3.1
e6/l
25.4
90.8
1.24
183
1508
(3021589) Normoblasts [#/volume] in Blood
323
2962
1.15
1.17
11.3
9.1
e9/l
0.0
0.0
0.50
269
2438
(3023511) Choriogonadotropin [Units/volume] in Urine
24
158
1.53
1.15
1.7
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
31
2.27
1.10
1.0
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
202
1799
1.16
1.08
3.9
3.0
e6/l
0.3
0.4
1.87
162
1351
(3012516) Albumin [Mass/volume] in Urine
206
1838
1.16
1.07
3.2
3.2
mg/l
1302.8
384.8
0.82
131
1151
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
139
1204
1.19
1.04
4.6
3.7
ng/l
291.4
320.7
0.05
103
895
(4035726)
70
565
1.26
1.04
1.3
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
46
1.97
1.04
1.0
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
46
1.97
1.04
1.0
1.2
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
85
703
1.23
1.02
2.0
1.8
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
66
530
1.27
1.02
4.3
3.7
mmol/l
1.2
1.2
0.02
59
462
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
117
1000
1.20
1.02
1.6
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
7
132
0.53
0.99
1.9
1.7
nmol/l
42.1
41.0
—
7
124
(3019150) Specific gravity of Urine by Refractometry
128
1472
0.85
0.99
3.6
4.0
kg/l
1.0
1.0
0.22
28
203
(3044927) Protein electrophoresis panel - Urine
13
77
1.70
0.95
1.3
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
51
1.77
0.94
2.0
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
200
1.41
0.94
2.3
1.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
15
93
1.62
0.94
1.3
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
7
37
1.90
0.94
3.1
2.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
217
1967
1.14
0.91
3.2
3.1
mmol/l
7.0
7.3
0.50
180
1643
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
63
1.76
0.90
1.0
1.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
29
2.08
0.89
1.2
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
12
71
1.70
0.89
1.2
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
56
1.80
0.88
1.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
11
64
1.73
0.86
1.1
1.8
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
24
170
1.42
0.86
2.2
2.3
%
182.2
181.4
0.02
24
162
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
8
44
1.83
0.86
1.3
1.3
mmol/l
1.8
1.9
—
8
44
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
124
1084
1.17
0.85
3.4
2.6
e6/l
1.4
1.1
0.28
79
612
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
71
590
1.22
0.84
2.6
2.4
u/l
29.3
30.9
0.18
59
495
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
45
1.79
0.84
1.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
45
1.79
0.84
1.5
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
254
2341
1.12
0.81
4.1
3.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
19
271
0.69
0.81
1.2
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
90
770
1.19
0.80
1.7
1.7
%
1.5
1.4
0.63
77
680
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
456
4345
1.11
0.80
3.6
3.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
171
1539
1.14
0.80
5.5
4.4
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
58
1.73
0.80
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
63
521
1.23
0.79
1.9
2.4
ug/l
4.7
6.3
0.57
49
454
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
33
1.82
0.79
1.0
1.0
—
—
—
0
0
(4281824)
12
74
1.63
0.78
1.2
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
12
74
1.63
0.78
1.2
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
37
287
1.30
0.78
1.9
1.8
mg/l
2.9
3.2
0.09
28
208
(3011397) Hemoglobin [Presence] in Urine by Test strip
137
1537
0.87
0.78
3.5
3.6
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
52
635
0.81
0.77
1.4
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
28
0.00
0.76
0.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
22
299
0.73
0.73
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
106
0.56
0.73
1.2
1.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
48
390
1.25
0.72
5.5
6.8
mmol/l
24.6
24.5
0.09
42
363
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
13
84
1.56
0.72
1.4
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
17
117
1.46
0.72
1.0
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
52
427
1.23
0.71
4.0
3.4
pmol/l
4.4
4.5
0.41
43
383
(3000093) Morphology [Interpretation] in Blood Narrative
9
57
1.59
0.71
1.3
1.2
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
18
126
1.44
0.70
3.3
3.2
nmol/l
0.8
0.9
0.48
13
98
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
126
1.44
0.70
1.2
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
126
1.44
0.70
1.2
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
41
1.71
0.70
1.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
58
1.56
0.70
1.2
1.7
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
11
69
1.60
0.68
1.1
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
5
27
1.86
0.68
1.0
1.4
nmol/l
120.4
154.5
—
5
27
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
42
1.67
0.68
2.1
1.7
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
7
42
1.67
0.68
1.1
1.0
mg/l
293.3
300.4
—
7
37
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
23
170
1.36
0.68
1.6
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
15
102
1.48
0.68
1.5
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
44
537
0.81
0.67
3.7
2.6
ml/min/173m2
58.4
67.0
0.65
15
230
(3007566) Smooth muscle Ab [Titer] in Serum
23
171
1.36
0.66
1.4
1.1
titre
36.0
67.3
—
5
15
(3051651) Icteric interference index of Serum or Plasma
7
44
1.60
0.65
2.6
2.9
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
29
1.73
0.64
4.0
3.2
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
8
49
1.64
0.62
1.4
1.3
—
64.4
—
0
5
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
275
2582
1.10
0.61
4.6
3.9
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
18
130
1.39
0.61
1.9
2.4
%
15.9
16.2
—
7
66
(3050129) First trimester maternal screen panel - Serum or Plasma
28
218
1.29
0.61
1.4
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
80
698
1.16
0.60
6.9
7.3
mmol/l
1.0
1.3
0.36
64
549
(44813793)
8
52
1.54
0.59
1.4
1.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
92
813
1.15
0.58
4.9
6.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
24
184
1.31
0.58
1.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
6
35
1.72
0.57
1.0
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
90
1.45
0.55
1.9
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
208
1938
1.10
0.55
3.8
3.8
ph
7.4
7.4
0.08
40
363
(3003740) Influenza virus B Ag [Presence] in Specimen
16
117
1.37
0.52
1.0
1.1
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
79
698
1.15
0.52
7.0
7.3
kpa
5.1
5.1
0.09
74
668
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
39
324
1.21
0.52
7.6
9.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
64
1.41
0.51
2.9
3.0
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
135
1.34
0.51
4.7
3.8
%
57.6
58.9
0.18
18
135
(3002256) Pathology report gross observation
95
852
1.13
0.50
1.3
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
34
280
1.22
0.49
1.6
2.0
g/l
1.7
1.5
0.46
29
244
(40761535) Cells panel - Urine sediment
46
538
0.85
0.49
3.6
3.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
148
1365
1.10
0.48
3.0
2.5
e6/l
6.0
7.0
0.42
136
1203
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
119
1.35
0.48
4.9
2.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
5
82
0.61
0.46
1.6
1.9
pg
31.6
32.3
—
5
82
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
103
1.37
0.45
3.0
3.2
—
2877.7
—
0
10
(3000991) Gas panel - Venous blood
57
500
1.15
0.43
10.3
7.9
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
31
1.62
0.43
1.2
2.5
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
17
131
1.30
0.42
4.4
3.5
e9/l
4.5
4.3
0.15
17
131
(1001926) Buprenorphine [Presence] in Urine by Screen method
14
184
0.76
0.42
4.3
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
187
1758
1.08
0.41
3.7
3.0
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
188
1768
1.08
0.41
1.7
1.6
mmol/l
1.4
1.4
0.38
168
1488
(3022689) Creatine [Moles/volume] in Urine
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
19
238
0.79
0.40
1.6
1.5
—
—
—
0
0
(4211845)
5
34
1.47
0.40
4.2
2.9
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.8
—
2.2
—
0
7
(3002385) Erythrocyte distribution width [Ratio]
551
5630
0.93
0.39
22.1
16.5
%
13.7
13.7
0.21
546
5521
(3019832) Treponema pallidum Ab [Presence] in Serum
72
647
1.12
0.39
1.4
1.6
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
10
71
1.41
0.39
1.1
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
46
401
1.16
0.39
4.3
4.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
18
142
1.27
0.38
1.2
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
25
206
1.22
0.38
1.2
1.3
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
5
36
1.39
0.38
1.2
1.1
u/l
31.6
15.7
—
5
30
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
5
36
1.39
0.38
2.6
1.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
136
0.73
0.38
1.6
1.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
5
37
1.35
0.37
2.6
1.7
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
71
1.27
0.36
4.3
1.8
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
6
43
1.40
0.35
1.3
1.6
u/field
0.2
3.1
—
6
31
(3044290) Cell count panel - Cerebral spinal fluid
17
136
1.26
0.34
1.1
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
32
371
0.86
0.33
1.3
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
127
1.27
0.33
1.6
1.5
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
6
86
0.70
0.33
1.2
1.1
%
143.2
120.7
—
6
80
(3028300) Cannabinoids [Presence] in Urine
20
241
0.83
0.32
3.5
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
12
92
1.31
0.32
1.8
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
52
1.35
0.31
2.6
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
20
240
0.83
0.31
3.5
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
20
240
0.83
0.31
3.5
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
391
1.13
0.30
1.5
1.5
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
16
129
1.25
0.30
1.8
2.2
g/l
129.5
130.4
—
10
99
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
23
270
0.85
0.29
1.3
1.4
—
—
—
0
0
(4034850)
24
204
1.18
0.29
8.0
9.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
13
103
1.27
0.28
1.9
1.6
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
17
205
0.83
0.28
1.2
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
8
63
1.27
0.28
1.6
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
52
471
1.11
0.27
1.5
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
8
66
1.21
0.26
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
73
0.68
0.26
1.6
1.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
171
1788
0.94
0.25
4.4
4.0
estimate
0.0
0.0
0.50
64
619
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
154
1467
1.06
0.25
4.7
5.1
ug/l
2.4
2.4
0.05
142
1312
(3014765) Yersinia sp identified in Stool by Organism specific culture
17
202
0.84
0.25
1.2
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
78
1.29
0.24
2.1
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
15
124
1.21
0.24
1.3
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
17
201
0.84
0.24
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
191
1836
1.05
0.23
1.4
1.4
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
5
38
1.32
0.23
1.2
1.1
u/l
112.2
79.5
—
5
33
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
116
1223
0.94
0.23
3.6
2.8
mmol/l
2.5
2.4
0.02
96
1072
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
95
0.73
0.22
1.1
1.1
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
3.0
—
71.7
—
0
10
(3002619) Bacteria identified in Specimen by Culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
105
0.76
0.21
1.6
1.6
%
65.0
62.3
—
8
105
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
117
1.20
0.20
1.9
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
117
1.20
0.20
1.4
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
14
0.00
0.20
0.0
2.6
—
—
—
0
0
(3000492) Spirometry study
68
636
1.08
0.20
1.8
1.4
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
6
49
1.23
0.20
1.5
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
25
222
1.13
0.19
1.4
1.3
miu/ml
298.3
242.5
0.24
11
108
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
154
0.84
0.19
1.3
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
30
270
1.12
0.19
1.1
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
53
1.13
0.18
1.0
1.2
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
58
1.21
0.18
1.7
1.3
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
7
59
1.19
0.18
1.6
1.2
mmol/l
6.8
6.7
—
7
54
(3014051) Protein [Presence] in Urine by Test strip
17
148
1.15
0.17
3.5
2.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
152
0.85
0.17
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
20
177
1.13
0.16
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
20
177
1.13
0.16
1.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
20
177
1.13
0.16
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
20
177
1.13
0.16
1.3
1.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
72
1.11
0.16
2.4
1.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
66
624
1.06
0.15
7.4
7.6
%
96.4
96.0
0.27
61
603
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
10
83
1.21
0.15
1.2
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
9
78
1.16
0.15
4.4
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
20
223
0.89
0.14
3.5
1.5
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
71
676
1.06
0.14
3.4
4.1
ug/l
5.7
15.3
0.84
56
553
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
100
0.80
0.13
1.6
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
14
159
0.88
0.13
4.6
2.0
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
11
95
1.16
0.11
2.4
1.8
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
13
147
0.88
0.11
1.3
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
13
147
0.88
0.11
1.3
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
126
1296
0.97
0.11
1.4
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
115
0.87
0.10
1.3
1.5
—
—
—
0
0
(40758558) Short blood count panel - Blood
171
1673
1.03
0.10
7.5
6.7
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
18
164
1.10
0.09
3.4
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
5
46
1.09
0.09
1.0
1.2
—
—
—
0
0
(4306422)
10
87
1.15
0.09
1.1
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
6
54
1.11
0.09
1.5
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
6
54
1.11
0.09
1.5
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
6
54
1.11
0.09
1.5
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
6
55
1.09
0.09
1.5
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
6
55
1.09
0.09
1.5
1.1
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
6
55
1.09
0.09
1.2
1.2
nmol/l
1.3
1.4
—
6
47
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
6
55
1.09
0.09
1.5
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
27
253
1.07
0.08
2.1
2.1
u/l
19.5
3653.1
—
7
108
(21494890) Protein electrophoresis panel - 24 hour Urine
5
61
0.82
0.08
1.6
2.5
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
64
1.09
0.08
1.4
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
15
164
0.91
0.08
1.2
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
127
1.10
0.08
1.6
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
46
441
1.05
0.07
1.9
1.8
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
71
0.84
0.07
4.2
3.9
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
36
343
1.05
0.07
1.6
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
22
235
0.93
0.07
1.8
1.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
80
0.87
0.07
13.0
2.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
55
569
0.96
0.07
6.6
3.8
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
10
89
1.13
0.07
2.5
2.0
u/ml
56.9
49.3
—
10
83
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
68
662
1.03
0.06
1.3
1.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
18
192
0.94
0.05
1.2
1.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
61
594
1.03
0.05
1.6
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
110
1.09
0.05
1.9
1.6
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
12
110
1.09
0.05
1.2
1.5
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
12
110
1.09
0.05
1.7
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
242
2398
1.01
0.04
3.4
2.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
115
1167
0.98
0.04
3.7
4.5
%
21.6
21.2
0.10
61
564
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
11
101
1.09
0.04
1.1
1.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
14
131
1.07
0.03
2.8
2.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
69
678
1.02
0.03
3.7
3.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
102
1.08
0.03
5.1
1.9
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
118
0.93
0.02
4.4
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
20
192
1.04
0.02
1.3
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
43
421
1.02
0.02
1.4
1.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
10
93
1.08
0.02
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
107
0.93
0.02
1.0
1.1
—
—
—
0
0
(4094501)
16
167
0.96
0.01
1.1
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
19
183
1.04
0.01
1.2
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
15
156
0.96
0.00
1.6
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
54
534
1.01
0.00
1.3
1.2
iu/ml
207.7
149.4
0.40
20
229
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
125
0.96
0.00
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
10
96
1.04
0.00
1.5
1.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
12
116
1.04
0.00
3.8
2.4
—
—
—
0
0
(40768793) Breast Pathology biopsy report
20
195
1.03
0.00
1.3
1.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
36
364
0.99
0.00
1.4
1.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
132
0.98
0.00
3.5
2.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
25
248
1.01
0.00
2.3
2.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
40
402
0.99
0.00
1.8
1.7
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
14
141
0.99
0.00
1.4
1.8
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
15
151
0.99
0.00
1.4
1.6
e6/l
12367.1
17381.0
—
8
112
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
159
1.01
0.00
3.8
1.8
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
17
169
1.01
0.00
1.2
1.3
mg/l
598.2
478.7
0.41
17
155
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
32
319
1.00
0.00
1.3
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
84
841
1.00
0.00
2.7
3.1
ug/l
0.8
0.7
0.11
56
568
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
5
50
1.00
0.00
1.6
1.1
—
105.7
—
0
7
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
6
69
0.87
0.00
1.2
1.9
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
71
0.99
0.00
2.0
1.6
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
5
52
0.96
0.00
1.4
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
5.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
70
1.00
0.00
3.1
2.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
6
68
0.88
0.00
5.5
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
6
68
0.88
0.00
5.5
1.6
—
—
—
0
0
(4268621)
6
65
0.92
0.00
2.2
2.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
78
0.90
0.00
2.0
1.5
—
—
—
0
0
(44790048)
7
76
0.92
0.00
1.9
1.7
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
343.8
—
0
5
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
6
68
0.88
0.00
5.5
1.6
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
10.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
7
0.00
0.00
0.0
1.0
—
17.9
—
0
7
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
6
64
0.94
0.00
1.0
1.2
—
—
—
0
0
(3001729) Color of Synovial fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
8.2
—
0
7
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(44790047)
7
76
0.92
0.00
1.9
1.7
—
—
—
0
0
(3023436) Glucagon [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
188.8
—
0
5
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
56
0.89
0.00
1.2
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
5.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
5
54
0.93
0.00
2.2
2.1
—
1.7
—
0
5
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(44806118)
7
76
0.92
0.00
1.9
1.7
—
—
—
0
0
(44790049)
7
76
0.92
0.00
1.9
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
59
1.02
0.00
1.2
1.9
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint ALLERGIC_CONTACT_DERMA_DRUGS_CONTACT_W_SKIN and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ALLERGIC_CONTACT_DERMA_DRUGS_CONTACT_W_SKIN | 1.27 [1.11, 1.45] | < 0.001 |
| Birth year | 0.991 [0.98, 1.0] | 0.055 |
During the follow-up period (1.1.1998 — 31.12.2019), 489 out of 3292 females with ALLERGIC_CONTACT_DERMA_DRUGS_CONTACT_W_SKIN died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ALLERGIC_CONTACT_DERMA_DRUGS_CONTACT_W_SKIN | 1.183 [1.01, 1.38] | 0.037 |
| Birth year | 0.988 [0.98, 1.0] | 0.016 |
During the follow-up period (1.1.1998 — 31.12.2019), 282 out of 1473 males with ALLERGIC_CONTACT_DERMA_DRUGS_CONTACT_W_SKIN died.
Mortality risk
Mortality risk for people of age
years, who have ALLERGIC_CONTACT_DERMA_DRUGS_CONTACT_W_SKIN.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.111% | 0.179% |
| 5 | 0.634% | 1.323% |
| 10 | 1.575% | 3.396% |
| 15 | 3.293% | 6.513% |
| 20 | 5.733% | 11.263% |
Relationships between endpoints
↥Index endpoint: ALLERGIC_CONTACT_DERMA_DRUGS_CONTACT_W_SKIN – Allergic contact dermatitis due to drugs in contact with skin
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data